Asia-Pacific OTC Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Asia-Pacific Over-The-Counter (OTC) Drugs Market Report is Segmented by Product Type (Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Minerals, and Supplements (VMS), Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Other Product Types), Formulation Type (Tablets, Liquids, Ointments, and Sprays), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacy), and Geography (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific). The Report Offers Market Sizes and Forecasts in Terms of Value (USD) for all the Abovementioned Segments.

Asia-Pacific OTC Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Asia-Pacific Over-the-counter (OTC) Drugs Market Size

View Global Report
Asia-Pacific Over-the-counter (OTC) Drugs Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Market Size (2025) USD 42.48 Billion
Market Size (2030) USD 63.28 Billion
CAGR (2025 - 2030) 8.30 %
Market Concentration Low

Major Players

Asia-Pacific Over-the-counter (OTC) Drugs Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Asia-Pacific Over-the-counter (OTC) Drugs Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Asia-Pacific Over-the-counter (OTC) Drugs Market Analysis

The Asia-Pacific Over-the-counter Drugs Market size is estimated at USD 42.48 billion in 2025, and is expected to reach USD 63.28 billion by 2030, at a CAGR of 8.3% during the forecast period (2025-2030).

The factors contributing to the growth of the Asia-Pacific over-the-counter (OTC) drugs market are high penetration in emerging countries such as India and China, increasing approval of OTC drugs, and the inclination of pharmaceutical companies toward OTC drugs over prescription drugs. Along with new accessibility channels in retail outlets, supermarkets are contributing to the growth of the OTC medication market in Asia-Pacific.

The widespread occurrence of pain-related issues, including back problems and various musculoskeletal conditions such as arthritis, osteoporosis, fibromyalgia, and sciatica, significantly drives the demand for analgesics in the region, thereby fueling the growth of the OTC drugs market. For instance, according to the 2022 National Health Survey (NHS) by the Australian Bureau of Statistics (ABS), published in June 2024, an estimated 4.0 million Australians, accounting for 16% of the population, reported having back problems. In addition, as per the same source, back problems ranked as the third leading cause of health burden, constituting 4.3% of the overall burden in Australia in 2023. In conclusion, the high prevalence of pain-related conditions, particularly back problems, underscores the critical role of analgesics in addressing these health issues. This demand is a key driver for the growth of the OTC drugs market, as evidenced by the significant health burden these conditions impose on the population.

Furthermore, the growing awareness of the management of various conditions, such as pain, using OTC drugs is expected to boost the usage of these drugs. For instance, in September 2023, Himalaya Wellness Company unveiled a new television advertising campaign for Rumalaya Active Spray, emphasizing swift and enduring pain relief for consumers. Centered around the theme, "Rumalaya Active Spray: Your Pain Relief Partner." The campaign underscores the offering of clinically tested, safe, and effective pain relief, with effects lasting up to six hours. This creates public awareness of the new OTC products and increases the demand for these products, boosting market growth over the study period.

However, the lack of awareness and drug abuse are expected to hinder the market growth over the forecast period.

Asia-Pacific Over-the-counter (OTC) Drugs Industry Overview

The over-the-counter drugs market in Asia-Pacific is fragmented and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products at lower prices. Companies like Sanofi, Dr. Reddy's Laboratories, Taisho Pharmaceutical Group, and Procter & Gamble hold significant market shares in the Asia-Pacific over-the-counter drugs market.

Asia-Pacific Over-the-counter (OTC) Drugs Market Leaders

  1. Boehringer Ingelheim International GmbH

  2. Procter & Gamble

  3. Sanofi SA

  4. Dr. Reddy's Laboratories

  5. Taisho Pharmaceutical Group

  6. *Disclaimer: Major Players sorted in no particular order
Asia-Pacific Over-the-counter (OTC) Drugs Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Asia-Pacific Over-the-counter (OTC) Drugs Market News

  • June 2024: Dr. Reddy's Laboratories Ltd inked a definitive deal with Haleon PLC to buy shares of Northstar Switzerland SARL, a subsidiary of Haleon. This acquisition focuses on Haleon's global portfolio of consumer healthcare brands in the nicotine replacement therapy ("NRT") category, excluding the United States. The portfolio includes Nicotinell, an over-the-counter brand in the NRT category, boasting a significant presence in more than 30 countries, including countries of Asia.
  • January 2024: Daiichi Sankyo Healthcare planned to launch an OTC version of Calonal tablets (acetaminophen), an antipyretic analgesic from Ayumi Pharmaceutical, in Japan.

Asia-Pacific Over-the-counter (OTC) Drugs Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Penetration in Emerging Markets with Increasing Approval of OTC Drugs
    • 4.2.2 Inclination of Pharmaceutical Companies to Switch from Rx to OTC Drugs
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness and Drug Abuse
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product Type
    • 5.1.1 Cough, Cold, and Flu Products
    • 5.1.2 Analgesics
    • 5.1.3 Dermatology Products
    • 5.1.4 Gastrointestinal Products
    • 5.1.5 Vitamins, Mineral, and Supplements (VMS)
    • 5.1.6 Weight-loss/Dietary Products
    • 5.1.7 Ophthalmic Products
    • 5.1.8 Sleeping Aids
    • 5.1.9 Other Product Types
  • 5.2 By Formulation Type
    • 5.2.1 Tablets
    • 5.2.2 Liquids
    • 5.2.3 Ointments
    • 5.2.4 Sprays
  • 5.3 By Distribution Channel
    • 5.3.1 Hospital Pharmacies
    • 5.3.2 Retail Pharmacies
    • 5.3.3 Online Pharmacy
  • 5.4 Geography
    • 5.4.1 China
    • 5.4.2 Japan
    • 5.4.3 India
    • 5.4.4 Australia
    • 5.4.5 South Korea
    • 5.4.6 Rest of Asia-Pacific

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Dr. Reddy's Laboratories
    • 6.1.2 Sanofi SA
    • 6.1.3 Haleon PLC
    • 6.1.4 Taisho Pharmaceutical Group
    • 6.1.5 Abbott Laboratories
    • 6.1.6 Dabur India Limited
    • 6.1.7 Procter & Gamble
    • 6.1.8 Reckitt Benckiser Group PLC
    • 6.1.9 Takeda Pharmaceutical Company Limited
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Asia-Pacific Over-the-counter (OTC) Drugs Industry Segmentation

As per the scope of this report, over-the-counter (OTC) drugs are medications that can be purchased without a prescription. They are considered safe and effective for self-treatment of common ailments when used as directed.

The Asia-Pacific OTC drugs market is segmented by product type, formulation type, distribution channel, and geography. By product type, the market is segmented into cough, cold, and flu products, analgesics, dermatology products, gastrointestinal products, vitamins, minerals, and supplements (VMS), weight loss/dietary products, ophthalmic products, sleeping aids, and other product types. By formulation type, the market is segmented into tablets, liquids, ointments, and sprays. By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. By geography, the market is segmented into China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific. For each segment, the market size and forecast are provided in terms of value (USD).

By Product Type Cough, Cold, and Flu Products
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Mineral, and Supplements (VMS)
Weight-loss/Dietary Products
Ophthalmic Products
Sleeping Aids
Other Product Types
By Formulation Type Tablets
Liquids
Ointments
Sprays
By Distribution Channel Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Geography China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Need A Different Region or Segment?
Customize Now

Asia-Pacific Over-the-counter (OTC) Drugs Market Research FAQs

How big is the Asia-Pacific Over-the-counter Drugs Market?

The Asia-Pacific Over-the-counter Drugs Market size is expected to reach USD 42.48 billion in 2025 and grow at a CAGR of 8.30% to reach USD 63.28 billion by 2030.

What is the current Asia-Pacific Over-the-counter Drugs Market size?

In 2025, the Asia-Pacific Over-the-counter Drugs Market size is expected to reach USD 42.48 billion.

Who are the key players in Asia-Pacific Over-the-counter Drugs Market?

Boehringer Ingelheim International GmbH, Procter & Gamble, Sanofi SA, Dr. Reddy's Laboratories and Taisho Pharmaceutical Group are the major companies operating in the Asia-Pacific Over-the-counter Drugs Market.

What years does this Asia-Pacific Over-the-counter Drugs Market cover, and what was the market size in 2024?

In 2024, the Asia-Pacific Over-the-counter Drugs Market size was estimated at USD 38.95 billion. The report covers the Asia-Pacific Over-the-counter Drugs Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Asia-Pacific Over-the-counter Drugs Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Asia-Pacific Over-the-counter (OTC) Drugs Industry Report

Statistics for the 2025 Asia-Pacific Over-the-counter (OTC) Drugs market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Over-the-counter (OTC) Drugs analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.